DealBook: U.S. Drug Firms Seek Inversion Deals to Evade Taxes

http://rss.nytimes.com/c/34625/f/640350/s/3c81e150/sc/1/l/0Ldealbook0Bnytimes0N0C20A140C0A70C140Cshire0Eand0Eabbvie0Ein0Etalks0Eover0E530Ebillion0Epharmaceutical0Emerger0C0Dpartner0Frss0Gemc0Frss/story01.htm

AbbVie has succeeded in winning tentative approval to buy the Irish drug maker Shire, and Mylan Laboratories said it would acquire the international generic drug business from Abbot Laboratories.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s